NSE - Delayed Quote INR
SENORES PHARMACEUTICALS L (SENORES.NS)
517.05
-15.45
(-2.90%)
At close: April 25 at 3:29:55 PM GMT+5:30
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | 10.4 | 28 |
| Low Estimate | 0 | 0 | 10.4 | 28 |
| High Estimate | 0 | 0 | 10.4 | 28 |
| Year Ago EPS | -- | -- | -- | 10.4 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 4.46B | 7.52B |
| Low Estimate | -- | -- | 4.46B | 7.52B |
| High Estimate | -- | -- | 4.46B | 7.52B |
| Year Ago Sales | -- | -- | -- | 4.46B |
| Sales Growth (year/est) | -- | -- | -- | 68.47% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 10.4 | 28 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SENORES.NS | -- | -- | -- | 169.23% |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
MARKSANS.NS Marksans Pharma Limited
216.03
-5.40%
DSNKY Daiichi Sankyo Company, Limited
24.85
+0.44%
NVS Novartis AG
112.14
+0.87%
AMGN Amgen Inc.
280.84
+0.36%
GILD Gilead Sciences, Inc.
103.17
-2.81%
NVO Novo Nordisk A/S
62.08
-0.88%
BMY Bristol-Myers Squibb Company
47.90
-1.62%
MRK Merck & Co., Inc.
82.74
+3.63%
PFE Pfizer Inc.
22.92
+0.61%
LLY Eli Lilly and Company
884.54
+2.89%